About Us

Better science faster

iPSC research has revolutionize biology through unlimited access to any type of cell, but the iPSC differentiation process into target cells has been challenging, limiting the impact of the approach. Until now.

At Elixirgen Scientific, we’re a team of scientists who have developed a technology that accelerates and removes the complexity from the iPSC differentiation process, bringing the full promise of induced pluripotent stem cells (iPSCs) or embryonic stem cells (ESCs) to life. It’s our mission to ensure that this technology can reach every lab, so that iPSCs can be the enabling innovation they were meant to be — accelerating advancements in human health through more accurate human cell-based models and opening the door to new applications based on human cells.

We are working towards a future where our technology improves lives by enabling new therapeutic modalities and devices; faster, more affordable drug discovery and development. We strive to enhance human health and advance scientific research. Better science faster.

Meet Our People

Minoru S.H. Ko MD, PhD

Founder, interim CEO, and Chief Scientific Officer

Bumpei Noda

Chief Financial Officer / Chief Operating Officer

Experience Elixirgen

Elixirgen Scientific is located in the Science and Technology Park at Johns Hopkins in Baltimore, an ideal research environment that allows Elixirgen Scientific’s scientists to conduct research at state-of-the-art facilities.